Histopathological and in vivo evidence of regucalcin as a protective molecule in mammary gland carcinogenesis

Experimental Cell Research

Volumn 330, Issue 2, 2015, Pages 325-335

  Marques, Ricardo ^a   Vaz, Cátia V ^a   Maia, Cláudio J ^a   Gomes, Madalena ^b   Gama, Adelina ^c   Alves, Gilberto ^a   Santos, Cecília R ^a   Schmitt, Fernando ^b,d,e,f   Socorro, Sílvia ^a  

^a UNIVERSITY OF BEIRA INTERIOR   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY OF TRÁS OS MONTES AND ALTO DOURO   (Portugal)

^d University of Porto   (Portugal)

^e UNIVERSITY OF TORONTO   (Canada)

^f UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Apoptosis; Breast cancer; Carcinogen; DMBA; Mammary gland; Regucalcin

Indexed keywords

CASPASE 3; KI 67 ANTIGEN; REGUCALCIN; 7,12 DIMETHYLBENZ[A]ANTHRACENE; CALCIUM BINDING PROTEIN; CARCINOGEN; RGN PROTEIN, HUMAN; SIGNAL PEPTIDE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER GRADING; CANCER GROWTH; CANCER INCIDENCE; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VIVO STUDY; NONHUMAN; PROTEIN EXPRESSION; RAT; TRANSGENIC RAT; TUMOR INVASION; ANIMAL; BIOSYNTHESIS; BREAST TUMOR; CARCINOGENESIS; CELL CYCLE CHECKPOINT; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; SPRAGUE DAWLEY RAT; UDDER;

ANIMALIA; RATTUS;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CALCIUM-BINDING PROTEINS; CARCINOGENESIS; CARCINOGENS; CASPASE 3; CELL CYCLE CHECKPOINTS; CELL PROLIFERATION; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KI-67 ANTIGEN; MAMMARY GLANDS, ANIMAL; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; RATS; RATS, SPRAGUE-DAWLEY; RATS, TRANSGENIC;

EID: 84919789386     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2014.08.007     Document Type: Article

References (28)

1. Yamaguchi M. Role of regucalcin in calcium signaling. Life Sci. 2000, 66:1769-1780.
2. Yamaguchi M. Regucalcin and cell regulation: role as a suppressor protein in signal transduction. Mol. Cell. Biochem. 2011, 353:101-137.
3. Marques R., Maia C.J., Vaz C., et al. The diverse roles of calcium-binding protein regucalcin in cell biology: from tissue expression and signalling to disease. Cell. Mol. Life Sci. 2014, 71:93-111.
4. Maia C., Santos C., Schmitt F., et al. Regucalcin is under-expressed in human breast and prostate cancers: effect of sex steroid hormones. J. Cell. Biochem. 2009, 107:667-676.
5. Laurentino S.S., Correia S., Cavaco J.E., et al. Regucalcin is broadly expressed in male reproductive tissues and is a new androgen-target gene in mammalian testis. Reproduction 2011, 142:447-456.
6. Zhou S.F., Mo F.R., Bin Y.H., et al. Serum immunoreactivity of SMP30 and its tissues expression in hepatocellular carcinoma. Clin. Biochem. 2011, 44:331-336.
7. Kim J., Kim S.H., Lee S.U., et al. Proteome analysis of human liver tumor tissue by two-dimensional gel electrophoresis and matrix assisted laser desorption/ionization-mass spectrometry for identification of disease-related proteins. Electrophoresis 2002, 23:4142-4156.
8. Suzuki S., Asamoto M., Tsujimura K., et al. Specific differences in gene expression profile revealed by cDNA microarray analysis of glutathione S-transferase placental form (GST-P) immunohistochemically positive rat liver foci and surrounding tissue. Carcinogenesis 2004, 25:439-443.
9. Yamaguchi M., Misawa H., Uchiyama S., et al. Role of endogenous regucalcin in bone metabolism: bone loss is induced in regucalcin transgenic rats. Int. J. Mol. Med. 2002, 10:377-383.
10. Ricardo S.A., Milanezi F., Carvalho S.T., et al. HER2 evaluation using the novel rabbit monoclonal antibody SP3 and CISH in tissue microarrays of invasive breast carcinomas. J. Clin. Pathol. 2007, 60:1001-1005.
11. Vandesompele J., De Preter K., Pattyn F., et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3. RESEARCH0034.
12. Huggins C., Grand L.C., Brillantes F.P. Mammary cancer induced by a single feeding of polymucular hydrocarbons, and its suppression. Nature 1961, 189:204-207.
13. Russo J., Russo I.H. Atlas and histologic classification of tumors of the rat mammary gland. J. Mammary Gland Biol. Neoplasia 2000, 5:187-200.
14. Liang J., Wu Y.L., Chen B.J., et al. The C-kit receptor-mediated signal transduction and tumor-related diseases. Int. J. Biol. Sci. 2013, 9:435-443.
15. Kashiwagi S., Yashiro M., Takashima T., et al. c-Kit expression as a prognostic molecular marker in patients with basal-like breast cancer. Br. J. Surg. 2013, 100:490-496.
16. Dowsett M., Nielsen T.O., A'Hern R., et al. Assessment of Ki67 in breast cancer: recommendations from the international Ki67 in breast cancer working group. J. Natl. Cancer Inst. 2011, 103:1656-1664.
17. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
18. Wang Y., Ji P., Liu J., et al. Centrosome-associated regulators of the G(2)/M checkpoint as targets for cancer therapy. Mol. Cancer 2009, 8:8.
19. Yun J., Chae H.D., Choy H.E., et al. p53 negatively regulates cdc2 transcription via the CCAAT-binding NF-Y transcription factor. J. Biol. Chem. 1999, 274:29677-29682.
20. Tsurusaki Y., Yamaguchi M. Overexpression of regucalcin modulates tumor-related gene expression in cloned rat hepatoma H4-II-E cells. J. Cell. Biochem. 2003, 90:619-626.
21. Nakagawa T., Sawada N., Yamaguchi M. Overexpression of regucalcin suppresses cell proliferation of cloned normal rat kidney proximal tubular epithelial NRK52E cells. Int. J. Mol. Med. 2005, 16:637-643.
22. Lin C.Y., Loven J., Rahl P.B., et al. Transcriptional amplification in tumor cells with elevated c-Myc. Cell 2012, 151:56-67.
23. Regan J.L., Kendrick H., Magnay F.A., et al. c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer. Oncogene 2012, 31:869-883.
24. Lawen A. Apoptosis-an introduction. Bioessays 2003, 25:888-896.
25. Luo X., Budihardjo I., Zou H., et al. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998, 94:481-490.
26. Elmore S. Apoptosis: a review of programmed cell death. Toxicol. Pathol. 2007, 35:495-516.
27. Schmitt C.A., Fridman J.S., Yang M., et al. Dissecting p53 tumor suppressor functions in vivo. Cancer Cell 2002, 1:289-298.
28. Hemann M.T., Lowe S.W. The p53-Bcl-2 connection. Cell Death Differ. 2006, 13:1256-1259.